Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Feminine Intimate Care Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Feminine Intimate Care Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Feminine Intimate Care Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Intimate Wash
    • 1.4.3 Masks
  • 1.5 Market by Application
    • 1.5.1 Global Feminine Intimate Care Market Share by Application: 2020 VS 2026
    • 1.5.2 Online Retailers
    • 1.5.3 Hypermarket
    • 1.5.4 Specialty Store
  • 1.6 Coronavirus Disease 2019 (Covid-19): Feminine Intimate Care Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Feminine Intimate Care Industry
      • 1.6.1.1 Feminine Intimate Care Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Feminine Intimate Care Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Feminine Intimate Care Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Feminine Intimate Care Market Perspective (2015-2026)
  • 2.2 Feminine Intimate Care Growth Trends by Regions
    • 2.2.1 Feminine Intimate Care Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Feminine Intimate Care Historic Market Share by Regions (2015-2020)
    • 2.2.3 Feminine Intimate Care Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Feminine Intimate Care Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Feminine Intimate Care Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Feminine Intimate Care Players by Market Size
    • 3.1.1 Global Top Feminine Intimate Care Players by Revenue (2015-2020)
    • 3.1.2 Global Feminine Intimate Care Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Feminine Intimate Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Feminine Intimate Care Market Concentration Ratio
    • 3.2.1 Global Feminine Intimate Care Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Feminine Intimate Care Revenue in 2019
  • 3.3 Feminine Intimate Care Key Players Head office and Area Served
  • 3.4 Key Players Feminine Intimate Care Product Solution and Service
  • 3.5 Date of Enter into Feminine Intimate Care Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Feminine Intimate Care Historic Market Size by Type (2015-2020)
  • 4.2 Global Feminine Intimate Care Forecasted Market Size by Type (2021-2026)

5 Feminine Intimate Care Breakdown Data by Application (2015-2026)

  • 5.1 Global Feminine Intimate Care Market Size by Application (2015-2020)
  • 5.2 Global Feminine Intimate Care Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Feminine Intimate Care Market Size (2015-2020)
  • 6.2 Feminine Intimate Care Key Players in North America (2019-2020)
  • 6.3 North America Feminine Intimate Care Market Size by Type (2015-2020)
  • 6.4 North America Feminine Intimate Care Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Feminine Intimate Care Market Size (2015-2020)
  • 7.2 Feminine Intimate Care Key Players in Europe (2019-2020)
  • 7.3 Europe Feminine Intimate Care Market Size by Type (2015-2020)
  • 7.4 Europe Feminine Intimate Care Market Size by Application (2015-2020)

8 China

  • 8.1 China Feminine Intimate Care Market Size (2015-2020)
  • 8.2 Feminine Intimate Care Key Players in China (2019-2020)
  • 8.3 China Feminine Intimate Care Market Size by Type (2015-2020)
  • 8.4 China Feminine Intimate Care Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Feminine Intimate Care Market Size (2015-2020)
  • 9.2 Feminine Intimate Care Key Players in Japan (2019-2020)
  • 9.3 Japan Feminine Intimate Care Market Size by Type (2015-2020)
  • 9.4 Japan Feminine Intimate Care Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Feminine Intimate Care Market Size (2015-2020)
  • 10.2 Feminine Intimate Care Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Feminine Intimate Care Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Feminine Intimate Care Market Size by Application (2015-2020)

11 India

  • 11.1 India Feminine Intimate Care Market Size (2015-2020)
  • 11.2 Feminine Intimate Care Key Players in India (2019-2020)
  • 11.3 India Feminine Intimate Care Market Size by Type (2015-2020)
  • 11.4 India Feminine Intimate Care Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Feminine Intimate Care Market Size (2015-2020)
  • 12.2 Feminine Intimate Care Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Feminine Intimate Care Market Size by Type (2015-2020)
  • 12.4 Central & South America Feminine Intimate Care Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Procter & Gamble
    • 13.1.1 Procter & Gamble Company Details
    • 13.1.2 Procter & Gamble Business Overview and Its Total Revenue
    • 13.1.3 Procter & Gamble Feminine Intimate Care Introduction
    • 13.1.4 Procter & Gamble Revenue in Feminine Intimate Care Business (2015-2020))
    • 13.1.5 Procter & Gamble Recent Development
  • 13.2 Himalaya Drug
    • 13.2.1 Himalaya Drug Company Details
    • 13.2.2 Himalaya Drug Business Overview and Its Total Revenue
    • 13.2.3 Himalaya Drug Feminine Intimate Care Introduction
    • 13.2.4 Himalaya Drug Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.2.5 Himalaya Drug Recent Development
  • 13.3 Unicharm
    • 13.3.1 Unicharm Company Details
    • 13.3.2 Unicharm Business Overview and Its Total Revenue
    • 13.3.3 Unicharm Feminine Intimate Care Introduction
    • 13.3.4 Unicharm Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.3.5 Unicharm Recent Development
  • 13.4 Kimberly-Clark
    • 13.4.1 Kimberly-Clark Company Details
    • 13.4.2 Kimberly-Clark Business Overview and Its Total Revenue
    • 13.4.3 Kimberly-Clark Feminine Intimate Care Introduction
    • 13.4.4 Kimberly-Clark Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.4.5 Kimberly-Clark Recent Development
  • 13.5 Elif Cosmetics
    • 13.5.1 Elif Cosmetics Company Details
    • 13.5.2 Elif Cosmetics Business Overview and Its Total Revenue
    • 13.5.3 Elif Cosmetics Feminine Intimate Care Introduction
    • 13.5.4 Elif Cosmetics Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.5.5 Elif Cosmetics Recent Development
  • 13.6 Nolken
    • 13.6.1 Nolken Company Details
    • 13.6.2 Nolken Business Overview and Its Total Revenue
    • 13.6.3 Nolken Feminine Intimate Care Introduction
    • 13.6.4 Nolken Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.6.5 Nolken Recent Development
  • 13.7 Johnson & Johnson
    • 13.7.1 Johnson & Johnson Company Details
    • 13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.7.3 Johnson & Johnson Feminine Intimate Care Introduction
    • 13.7.4 Johnson & Johnson Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.7.5 Johnson & Johnson Recent Development
  • 13.8 Sanofi
    • 13.8.1 Sanofi Company Details
    • 13.8.2 Sanofi Business Overview and Its Total Revenue
    • 13.8.3 Sanofi Feminine Intimate Care Introduction
    • 13.8.4 Sanofi Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.8.5 Sanofi Recent Development
  • 13.9 Bayer Group
    • 13.9.1 Bayer Group Company Details
    • 13.9.2 Bayer Group Business Overview and Its Total Revenue
    • 13.9.3 Bayer Group Feminine Intimate Care Introduction
    • 13.9.4 Bayer Group Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.9.5 Bayer Group Recent Development
  • 13.10 Namyaa Skincare
    • 13.10.1 Namyaa Skincare Company Details
    • 13.10.2 Namyaa Skincare Business Overview and Its Total Revenue
    • 13.10.3 Namyaa Skincare Feminine Intimate Care Introduction
    • 13.10.4 Namyaa Skincare Revenue in Feminine Intimate Care Business (2015-2020)
    • 13.10.5 Namyaa Skincare Recent Development
  • 13.11 CTS Group
    • 10.11.1 CTS Group Company Details
    • 10.11.2 CTS Group Business Overview and Its Total Revenue
    • 10.11.3 CTS Group Feminine Intimate Care Introduction
    • 10.11.4 CTS Group Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.11.5 CTS Group Recent Development
  • 13.12 Combe Incorporated
    • 10.12.1 Combe Incorporated Company Details
    • 10.12.2 Combe Incorporated Business Overview and Its Total Revenue
    • 10.12.3 Combe Incorporated Feminine Intimate Care Introduction
    • 10.12.4 Combe Incorporated Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.12.5 Combe Incorporated Recent Development
  • 13.13 SweetSpot Labs
    • 10.13.1 SweetSpot Labs Company Details
    • 10.13.2 SweetSpot Labs Business Overview and Its Total Revenue
    • 10.13.3 SweetSpot Labs Feminine Intimate Care Introduction
    • 10.13.4 SweetSpot Labs Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.13.5 SweetSpot Labs Recent Development
  • 13.14 Ciaga
    • 10.14.1 Ciaga Company Details
    • 10.14.2 Ciaga Business Overview and Its Total Revenue
    • 10.14.3 Ciaga Feminine Intimate Care Introduction
    • 10.14.4 Ciaga Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.14.5 Ciaga Recent Development
  • 13.15 Zeta Farmaceutici
    • 10.15.1 Zeta Farmaceutici Company Details
    • 10.15.2 Zeta Farmaceutici Business Overview and Its Total Revenue
    • 10.15.3 Zeta Farmaceutici Feminine Intimate Care Introduction
    • 10.15.4 Zeta Farmaceutici Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.15.5 Zeta Farmaceutici Recent Development
  • 13.16 Edgewell Personal Care
    • 10.16.1 Edgewell Personal Care Company Details
    • 10.16.2 Edgewell Personal Care Business Overview and Its Total Revenue
    • 10.16.3 Edgewell Personal Care Feminine Intimate Care Introduction
    • 10.16.4 Edgewell Personal Care Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.16.5 Edgewell Personal Care Recent Development
  • 13.17 Emilia Personal Care
    • 10.17.1 Emilia Personal Care Company Details
    • 10.17.2 Emilia Personal Care Business Overview and Its Total Revenue
    • 10.17.3 Emilia Personal Care Feminine Intimate Care Introduction
    • 10.17.4 Emilia Personal Care Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.17.5 Emilia Personal Care Recent Development
  • 13.18 Nua Woman
    • 10.18.1 Nua Woman Company Details
    • 10.18.2 Nua Woman Business Overview and Its Total Revenue
    • 10.18.3 Nua Woman Feminine Intimate Care Introduction
    • 10.18.4 Nua Woman Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.18.5 Nua Woman Recent Development
  • 13.19 Kao Corporation
    • 10.19.1 Kao Corporation Company Details
    • 10.19.2 Kao Corporation Business Overview and Its Total Revenue
    • 10.19.3 Kao Corporation Feminine Intimate Care Introduction
    • 10.19.4 Kao Corporation Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.19.5 Kao Corporation Recent Development
  • 13.20 Bodywiseuk
    • 10.20.1 Bodywiseuk Company Details
    • 10.20.2 Bodywiseuk Business Overview and Its Total Revenue
    • 10.20.3 Bodywiseuk Feminine Intimate Care Introduction
    • 10.20.4 Bodywiseuk Revenue in Feminine Intimate Care Business (2015-2020)
    • 10.20.5 Bodywiseuk Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Feminine Intimate Care status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Feminine Intimate Care development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Procter & Gamble
    Himalaya Drug
    Unicharm
    Kimberly-Clark
    Elif Cosmetics
    Nolken
    Johnson & Johnson
    Sanofi
    Bayer Group
    Namyaa Skincare
    CTS Group
    Combe Incorporated
    SweetSpot Labs
    Ciaga
    Zeta Farmaceutici
    Edgewell Personal Care
    Emilia Personal Care
    Nua Woman
    Kao Corporation
    Bodywiseuk

    Market segment by Type, the product can be split into
    Intimate Wash
    Masks
    Market segment by Application, split into
    Online Retailers
    Hypermarket
    Specialty Store

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Feminine Intimate Care status, future forecast, growth opportunity, key market and key players.
    To present the Feminine Intimate Care development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Feminine Intimate Care are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now